The Contribution of Biologic Medicines to Public Health

Panel presentations and facilitated discussion to discuss stakeholders perspectives, roles and responsibiliies in ensuring sustainability off innovation. Hear perspectives from: the clinic, the patient community, indstry, and health economics:

-- The role of biologics in addressing complex and hard to treat diseases such as cancer and the overall value offered by this class of medicines to patients, their caregivers, and their healthcare providers.
-- The special characteristics of biologics that hold implications for decisions regarding R&D, approval and use
-- What is being done to expand appropriate patient access to needed biologic medicines in a financially sustainable way and what more can be done.
-- How stakeholders can work together to ensure that the appropriate use of biologics deliver maximum benefit and value to patients and societies and preserve incentives for continued innovation